Novartis First Half Net Profits up 29 Percent
34 Articles
34 Articles
In the second quarter, the Basel-based company's sales increased by 12 percent to $14 billion.
France’s top court restores collective abuse penalties against Novartis and Roche
Novartis and Roche have vowed to continue fighting allegations that they unlawfully spread defamatory claims about cheaper eye disease treatments after France’s Court of Cassation backed a €444 million antitrust fine against the companies.
The Basel-based pharma giant can come up with figures that exceed all expectations. The CEO is wiping away that there are serious uncertainties, especially in the USA. Novartis CEO Vas Narasimhan. Image: keystoneThe Basel-based pharma giant can come up with figures that exceed all expectations.The CEO is wiping away that there are great uncertainties, especially in the USA.Pascal Michel Novartis CEO Vas Narasimhan has two favorite words, "strong…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium